Medical Device Regulatory Services – Global Hub | RABT Global

Global Medical Device Regulatory Expertise — CE Marking, FDA & Beyond

RABT Global is a specialist medical device regulatory consulting firm providing end-to-end device regulatory services — FDA 510(k), CE marking under EU MDR, UK MHRA, ISO 13485, and GCC registration — for device manufacturers worldwide.

Tell us your device and your target markets — we’ll map your fastest, most cost-effective route to approval.

Get a Free Regulatory Assessment

Medical device regulatory consultants reviewing technical files

Medical device regulation is moving faster — and getting stricter — than ever. EU MDR and IVDR have rewritten what it takes to keep a device on the market in Europe, and FDA expectations for Quality, clinical evidence, and post-market surveillance continue to rise.

RABT Global delivers specialist device regulatory support across every major framework — FDA, EU MDR/IVDR, UK MHRA, ISO 13485, and GCC — under a single accountable team.

From classification through post-market vigilance, we help manufacturers enter and stay in their target markets with confidence.

500+
Device Submissions
40+
Countries Covered
17
Device Sub-Services
15+
Years Experience

Our Medical Device Regulatory Services — By Region

Dedicated regional teams covering every major medical device regulatory framework.

🇺🇸

USA — FDA

  • FDA 510(k) Submission
  • FDA PMA Services
  • De Novo Classification
  • US FDA Agent Services
  • FDA Device Classification
🇪🇺

Europe — EU MDR/IVDR

  • CE Marking Consulting
  • EU MDR Compliance
  • EU IVDR Compliance
  • Clinical Evaluation (CER)
  • Post-Market Surveillance
  • EU Authorised Representative
🇬🇧

UK — MHRA

  • UK MHRA Registration
  • UKCA Marking Support
  • Post-Brexit Device Compliance
  • MHRA Liaison
🌍

Middle East — GCC

  • UAE MOHAP Registration
  • Saudi SFDA Registration
  • Kuwait / Qatar / Bahrain / Oman
  • GCC MRA Strategy


 Lifecycle

Medical Device Regulatory Services — By Lifecycle Stage

From classification to post-market vigilance — a single specialist partner at every stage.

1

Classification & Strategy

Device classification (FDA/EU MDR/IVDR/MHRA), regulatory pathway selection, pre-submission strategy, and market entry roadmap.

2

Technical Documentation

510(k) dossier, EU MDR Technical File (Annex II & III), CE technical documentation, and ISO 13485 QMS implementation.

3

Clinical Evidence

Clinical Evaluation Reports (CER), PMCF plans, equivalence assessment, and literature review strategy.

4

Submission & Approval

FDA 510(k)/PMA/De Novo filing, CE marking conformity assessment, EUDAMED registration, and health authority liaison.

5

Post-Market Compliance

Post-Market Surveillance (PMS), PMSR/PSUR reporting, vigilance & FSCA, and lifecycle submission management.

Regulatory Frameworks & Services at a Glance

Framework / Region RABT Global Services
USA — FDA 510(k), PMA, De Novo, US Agent, Device Classification
Europe — EU MDR/IVDR CE Marking, MDR/IVDR compliance, CER, PMS, EU Authorised Representative
UK — MHRA MHRA Registration, UKCA Marking, Post-Brexit Compliance, MHRA Liaison
Middle East — GCC UAE MOHAP, Saudi SFDA, Kuwait/Qatar/Bahrain/Oman, GCC MRA Strategy
ISO 13485 Gap analysis, QMS implementation, MDSAP, audit preparation
Combination Products FDA designation, EU MDR borderline, drug-device strategy

Key Medical Device Services

A curated set of the services manufacturers ask us for most — explore the full 17 below.

🇺🇸

FDA 510(k) Submission

Strategy, dossier prep, Q-Sub management, and FDA response handling.

🇪🇺

EU MDR / IVDR Compliance

Technical docs, CER, EUDAMED, Notified Body liaison, MDD transition.

🇬🇧

UK MHRA Registration

UKCA marking, post-Brexit device registration, MHRA liaison.

🌍

GCC Device Registration

UAE MOHAP, Saudi SFDA, Kuwait, Qatar, Bahrain, Oman strategy.

🔬

Clinical Evaluation Reports

CER, PMCF plans, SSCP, and literature search support.

📊

Post-Market Surveillance

PMS plans, PMSR/PSUR, vigilance, FSCA, and retainer model.

📋

ISO 13485 QMS Consulting

Gap analysis, QMS implementation, MDSAP, audit preparation.

⚗️

Combination Products

FDA designation, EU MDR borderline, drug-device strategy.

💻

SaMD / Digital Health

AI/ML devices, clinical decision support, wearables, patient apps.

Device Types Covered by RABT Global

From implantables to AI-driven SaMD — we know your device class and its regulatory nuances.

🦴

Implantable

  • Orthopaedic implants
  • Cardiovascular devices
  • Neuromodulation
  • Ophthalmic implants
🧬

IVD / Diagnostics

  • Molecular diagnostics
  • Point-of-care testing
  • Immunology & serology
  • Companion diagnostics
💻

SaMD / Digital Health

  • AI/ML-based devices
  • Clinical decision support
  • Wearable health monitors
  • Patient apps (SaMD)
⚗️

Combination Products

  • Drug-device combos
  • Biologic-device combos
  • FDA jurisdiction strategy
  • EU borderline assessment

Why Medical Device Manufacturers Choose RABT Global

End-to-end medical device regulatory services from a single specialist partner — no outsourcing, no fragmentation. Dedicated teams of FDA specialists, EU MDR experts, ISO 13485 consultants, and CER clinical scientists coordinate parallel submissions across FDA, EU MDR, MHRA, and GCC markets, with proactive regulatory intelligence on the rapidly changing device landscape.

Global medical device regulatory team

Frequently Asked Questions

What medical device regulatory services does RABT Global offer?

End-to-end services across FDA 510(k)/PMA/De Novo, CE marking under EU MDR, EU IVDR, UK MHRA/UKCA, ISO 13485, and GCC device registration — all delivered by dedicated specialist teams.

Do you support Class I–III and IVD Class A–D devices?

Yes. We work across all device classifications including implantables, IVDs, SaMD, and combination products, with regulatory pathways tailored to each class and market.

Can you coordinate parallel submissions in multiple markets?

Multi-jurisdictional coordination is a core strength — we run parallel submissions across FDA, EU MDR, MHRA, and GCC markets to compress your global market entry timeline.

Do you provide EU Authorised Representative and US FDA Agent services?

Yes. We act as your statutory EU MDR/IVDR Authorised Representative and as your 21 CFR 807.40 US Agent, handling ADER and FDA correspondence on your behalf.

Ready to Map Your Global Device Approval Route?

Tell us your device and your target markets — we’ll come back with the fastest, most cost-effective regulatory pathway across FDA, EMA, MHRA, and GCC.

Book Your Free Assessment

Scroll to Top